Short-and long-term treatment of mouse cortical primary astrocytes with β-amyloid differentially regulates the mRNA Expression of L-type calcium channels

Pharmacology

Volumn 93, Issue 1-2, 2014, Pages 24-31

  Daschil, Nina ^a   Geisler, Stefanie ^b   Obermair, Gerald J ^b   Humpel, Christian ^a  

^a Department of Psychiatry and Psychotherapy University Clinic for General and Social Psychiatry ^*  (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Astrocytes; L type calcium channel; mRNA; Reverse transcription polymerase chain reaction; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CALCIUM CHANNEL L TYPE; CAV1.2 ALPHA1 PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL CAV1.3; GLUTAMATE SYNTHASE; PROTEIN KINASE C ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; FEMALE; INCUBATION TIME; LONG TERM CARE; MALE; MOUSE; MURINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT COURSE THERAPY; TREATMENT DURATION; ASTROCYTE CULTURE; BRAIN CELL; CELL ACTIVATION; MACROGLIA;

AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; MALE; MICE; NERVE TISSUE PROTEINS; RNA, MESSENGER;

EID: 84892412075     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000357383     Document Type: Article

References (32)

1. Landfield PW: 'Increased calcium-current' hypothesis of brain aging. Neurobiol Aging 1987; 8: 346-347.
2. Khachaturian ZS: Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 1987; 8: 345-346.
3. Thibault O, Gant JC, Landfield PW: Expansion of the calcium hypothesis of brain aging in Alzheimer's disease: minding the store. Aging Cell 2007; 6: 307-317. (Pubitemid 46785136)
4. Catterall WA: Structure and regulation of voltage-gated Ca 2+ channels. Annu Rev Cell Dev Biol 2000; 16: 521-555.
5. Obermair GJ, Flucher BE: Neuronal functions of auxiliary calcium channel subunits; in Stephens G, Mochida S (eds): Modulation of Presynaptic Calcium Channels. Dordrecht, Springer Science, 2013, pp 29-59.
6. MacVicar BA: Voltage-dependent calcium channels in glial cells. Science 1984; 226: 1345-1347. (Pubitemid 15215594)
7. Latour I, Hamid J, Beedle AM, Zamponi GW, MacVicar BA: Expression of voltage-gated Ca 2+ channel subtypes in cultured astrocytes. Glia 2003; 41: 347-353. (Pubitemid 36314148)
8. D'Ascenzo M, Vairano M, Andreassi C, Navarra P, Azzena GB, Grassi C: Electrophysiological and molecular evidence of L-(Ca V 1), N-(Ca V 2.2), and R-(Ca V 2.3) type Ca 2+ channels in rat cortical astrocytes. Glia 2004; 45: 354-363. (Pubitemid 38332436)
9. Sofroniew MV, Vinters HV: Astrocytes: biology and pathology. Acta Neuropathol 2010; 119: 7-35.
10. Nishiyama A, Yang Z, Butt A: Astrocytes and NG2-glia: what's in a name? J Anat 2005; 207: 687-693. (Pubitemid 43019728)
11. Westenbroek RE, Bausch SB, Lin RCS, Franck JE, Noebels JL, Catterall WA: Upregulation of L-type Ca 2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci 1998; 18: 2321-2334.
12. Willis M, Kaufmann WA, Wietzorrek G, Hutter-Paier B, Moosmang S, Humpel C, Hofmann F, Windisch M, Knaus HG, Marksteiner J: L-type calcium channel Ca V 1.2 in transgenic mice overexpressing human AβPP751 with the London (V717I) and Swedish (K670M/N671L) mutations. J Alzheimers Dis 2010; 20: 1167-1180.
13. Burgos M, Pastor MD, Gonzalez JC, Martinez-Galan JR, Vaquero CF, Fradejas N, Benavides A, Hernandez-Guijo JM, Tranque P, Calvo S: PKCε upregulates voltage-dependent calcium channels in cultured astrocytes. Glia 2007; 55: 1437-1448. (Pubitemid 47461159)
14. Yan E, Li B, Gu L, Hertz L, Peng L: Mechanisms for L-channel-mediated increase in [Ca 2+[ i and its reduction by anti-bipolar drugs in cultured astrocytes combined with its mRNA expression in freshly isolated cells support the importance of astrocytic L-channels. Cell Calcium 2013; 54: 335-342.
15. MacVicar BA, Hochman D, Delay MJ, Weiss S: Modulation of intracellular Ca ++ in cultured astrocytes by influx through voltage-activated Ca ++ channels. Glia 1991; 4: 448-455.
16. Daschil N, Obermair GJ, Flucher BE, Stefanova N, Hutter-Paier B, Windisch M, Humpel C, Marksteiner J: Ca V 1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model. J Alzheimers Dis 2013; 37: 439-451.
17. Moser KV, Humpel C: Blood-derived serum albumin contributes to neurodegeneration via astroglial stress fiber formation. Pharmacology 2007; 80: 286-292. (Pubitemid 47557263)
18. Zassler Z, Blasig I, Humpel C: Protein delivery of caspase-3 induces cell death in malignant C6 glioma, primary astrocytes and immortalized and primary brain capillary endothelial cells. J Neurooncol 2005; 71: 127-134. (Pubitemid 40796293)
19. Schlick B, Flucher BE, Obermair GJ: Voltageactivated calcium channel expression profiles in mouse brain and cultured hippocampal neurons. Neuroscience 2010; 167: 786-798.
20. Vandesompele J, de Preter K, Pattyn F, Poppe B, van Roy N, de Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
21. Nelson TJ, Cui C, Luo Y, Alkon DL: Reduction of β-amyloid levels by novel protein kinase Cε activators. J Biol Chem 2009; 284: 34514-34521.
22. Harvey RD, Hell JW: Ca V 1.2 signaling complexes in the heart. J Mol Cell Cardiol 2013; 58: 143-152.
23. Hall DD, Davare MA, Shi M, Allen ML, Weisenhaus M, McKnight GS, Hell JW: Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Ca V 1.2 via A-kinase anchor protein 150 in neurons. Biochemistry 2007; 46: 1635-1646.
24. Won CL, Oh YS: cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res 2000; 887: 250-258. (Pubitemid 32008046)
25. Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y: Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun 1987; 149: 665-671. (Pubitemid 18023031)
26. Salinero O, Moreno-Flores MT, Ceballos ML, Wandosell F: β-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J Neurosci Res 1997; 47: 216-223. (Pubitemid 27053380)
27. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990; 250: 279-282.
28. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE: β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376-389.
29. Pentreath VW, Mead C: Responses of cultured astrocytes, C6 glioma and 1321NI astrocytoma cells to amyloid β-peptide fragments. Nonlinearity Biol Toxicol Med 2004; 2: 45-63.
30. Abramov AY, Canevari L, Duchen MR: Calcium signals induced by amyloid β peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 2004; 1742: 81-87. (Pubitemid 39601768)
31. Scragg JL, Fearon IM, Boyle JP, Ball SG, Varadi G, Peers C: Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca 2+ channels. FASEB J 2005; 19: 150-152. (Pubitemid 40069948)
32. Brera B, Serrano A, de Ceballos ML: β-Amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol Dis 2000; 7: 395-405.